Candriam S.C.A. trimmed its holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 2.3% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 719,206 shares of the biopharmaceutical company’s stock after selling 16,678 shares during the quarter. Candriam S.C.A. owned 1.14% of Xenon […]